N
Novacept
Novacept design, develop, manufacture & market innovative therapeutic devices to improve quality of women healthcare cost-effective manner
About Novacept
Novacept, founded in London in 2019 by Vaideshwar Sekar, is a provider of digital transformation, technology, and business advisory services. The company leverages generative AI to assist clients with elevating customer service, optimizing retail operations, and improving HR processes. Novacept's offerings are designed to help businesses with tasks such as running targeted marketing campaigns and acquiring customers.
Read full description
The company's product portfolio includes NovaConnect, a tool for sales and marketing that aids in lead management, opportunity management, and customer relationship management. Another product, NovaAI, is designed to support business growth through smart tools and real-time data. Novacept serves a range of industries, providing AI-powered solutions for personalized product design, 24/7 customer service, and predictive maintenance. For the retail sector, its tools predict purchasing trends and manage inventory. In HR, the solutions assist with matching ideal candidates and enhancing onboarding processes.
The firm's business model appears to be centered on providing bespoke AI solutions and consulting services. It caters to a variety of clients, from start-ups to global enterprises, by creating tailored generative AI models to meet their specific challenges and objectives. This involves an initial needs assessment, seamless integration with existing systems, and providing training and ongoing support to client teams.
At a glance
- Status
- Acquired
- Founded
- 1995
- Headquarters
- Palo Alto, United States
- Open positions
- None listed
- Dealroom signal
- 21.0/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
- Links
- Website
Latest news
Press, funding announcements and product moves mentioning Novacept.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Mar 2004 | $325M | $325M | Cytyc | — |
| LATE VC✓Equity / VC | Mar 2002 | $30M | $120M | NEA · Three Arch Partners | — |
Growth signals
Latest recorded traffic for Novacept is 0 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
NEA
Three Arch Partners
Other known investors1 additional known investor
- CYCytyc
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Novacept on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Novacept’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.